Visceral Pain From the Upper Urinary Tract - a Trial on the Effect of Morphine and Oxycodone in Patients Undergoing PCNL
NCT ID: NCT00784472
Last Updated: 2012-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
55 participants
INTERVENTIONAL
2008-12-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary outcome: side effect to the opioids, pain score, pain threshold to electrical stimulation and pressure before and after operation, pharmacogenetics, size of referred pain area.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oxycodone
oxycodone
intravenous according to patients weight, pn.
morphine
morphine
intravenous administration according to patients weight, pn.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oxycodone
intravenous according to patients weight, pn.
morphine
intravenous administration according to patients weight, pn.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for PCNL
Exclusion Criteria
* Allergy to morphine or oxycodone
* Use of opioids the last 48 hours before PCNL
* Pregnancy
* Nursing mothers
* Present JJ-stent in the ureter
* Previous urinary stone disease on the opposite site
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University Hospital
OTHER
Katja venborg Pedersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katja venborg Pedersen
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Palle Osther, Professor
Role: STUDY_CHAIR
Hospital Little Belt, Fredericia
katja Venborg Pedersen, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Little Belt, Fredericia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Little Belt, Fredericia
Fredericia, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VEN 1
Identifier Type: -
Identifier Source: org_study_id